SCHEMBL24378465

SCHEMBL24378465

Cc1nc(-c2ccn(C)n2)cs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 1/20 0.42
KMT2A Q03164 1/20 0.42
ALDH1A1 P00352 4/20 0.42
GAA P10253 3/20 0.42
RECQL P46063 2/20 0.42
KDM4E B2RXH2 2/20 0.42
POLB P06746 2/20 0.42
HPGD P15428 2/20 0.42
MAPT P10636 1/20 0.42
ESR2 Q92731 1/20 0.42
TSHR P16473 1/20 0.41
NTRK1 P04629 1/20 0.41
KDM4A O75164 1/20 0.41
KDM4B O94953 1/20 0.41
KDM5C P41229 1/20 0.41
KDM5B Q9UGL1 1/20 0.41
RAB9A P51151 3/20 0.40
KEAP1 Q14145 1/20 0.40
HTT P42858 1/20 0.40
TRIM24 O15164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27015063 0.79 DYRK1A (0.48) ECE1ALDH1A1GAARECQLKDM4E
SCHEMBL27009169 0.79 ECE1 (0.42) ECE1ALDH1A1GAARECQLKDM4E
SCHEMBL24359598 0.78 GAA (0.52) ECE1ALDH1A1GAARECQLKDM4E
SCHEMBL18157906 0.76 KMT2A (0.64) KMT2AALDH1A1KDM4EKDM4AKDM4B
SCHEMBL24378674 0.72 PDE10A (0.50) KMT2AALDH1A1KDM4EHPGDTSHR
SCHEMBL12605589 0.70 ALDH1A1 (0.47) ALDH1A1GAARECQLKDM4EPOLB
SCHEMBL12970276 0.69 ALDH1A1 (0.53) ECE1KMT2AALDH1A1GAARECQL
SCHEMBL15182828 0.68 ALDH1A1 (0.51) ECE1KMT2AALDH1A1GAARECQL
SCHEMBL2053087 0.68 MET (0.42) KMT2AKEAP1PIK3CDPIP5K1CPIK3CA
SCHEMBL14401137 0.68 CDK4 (0.47) KMT2AALDH1A1KDM4EMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022086993-A1 NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME TME THERAPEUTICS LLC (US) 2022-04-28 WO disclosed